![Sara Sande](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Sara Sande
Directeur/Membre du Conseil chez
EXPRES2ION BIOTECH HOLDING AB
Profil
Sara Sande is currently Director at Biosyntia ApS, Independent Director at Expres2ion Biotech Holding AB since 2021, Director at ExpreS2ion Biotechnologies ApS, Director at Agreena ApS, Director at Monta ApS, Vice President at Origio A, and Partner at Danmarks Eksport- og Investeringsfond.
Former positions include Independent Director at Hydract A, Head-Grain & Beverages Sales at Novozymes A, and Vice President-Global Commercial Development at CooperSurgical, Inc. Education includes a graduate degree from the University of Copenhagen conferred in 2002.
Postes actifs de Sara Sande
| Sociétés | Poste | Début |
|---|---|---|
| EXPRES2ION BIOTECH HOLDING AB | Directeur/Membre du Conseil | 26/05/2021 |
Origio A/S
 Origio A/S BiotechnologyHealth Technology Manufactures and markets assisted reproduction technologies and related human reproductive products | Corporate Officer/Principal | - |
Biosyntia ApS
 Biosyntia ApS BiotechnologyHealth Technology Provides services in synthetic biology and metabolic engineering fields | Directeur/Membre du Conseil | - |
Agreena ApS
 Agreena ApS Packaged SoftwareTechnology Services Operates as an agricultural technology company that offers soil carbon platform | Directeur/Membre du Conseil | - |
Monta ApS
 Monta ApS Packaged SoftwareTechnology Services Provides EV ecosystem software solutions | Directeur/Membre du Conseil | - |
ExpreS2ion Biotechnologies ApS
 ExpreS2ion Biotechnologies ApS BiotechnologyHealth Technology Operates as a biotech company which engages in the field of protein production in Drosophila Schneider-2 cells | Directeur/Membre du Conseil | - |
Danmarks Eksport- og Investeringsfond
 Danmarks Eksport- og Investeringsfond Investment ManagersFinance EIFO invests in small and medium-sized companies located in Denmark. The firm targets companies operating across a broad range of sectors and industries. It provides financing in the form of equity and debt with an investment size of DKK 5 - 200 million. It also takes a seat on the board of directors. | Private Equity Investor | - |
Anciens postes connus de Sara Sande
| Sociétés | Poste | Fin |
|---|---|---|
CooperSurgical, Inc.
 CooperSurgical, Inc. Medical SpecialtiesHealth Technology Produces and markets medical devices for fertility & women's health care | Corporate Officer/Principal | - |
Novozymes A/S
 Novozymes A/S Chemicals: SpecialtyProcess Industries Manufactures and sells specialty chemicals | Corporate Officer/Principal | - |
| ░░░░░░░ ░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | - |
Formation de Sara Sande
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
43
Relations au 1er degré
11
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 11 |
|---|---|
Novozymes A/S
Novozymes A/S Chemicals: SpecialtyProcess Industries Manufactures and sells specialty chemicals | Process Industries |
CooperSurgical, Inc.
CooperSurgical, Inc. Medical SpecialtiesHealth Technology Produces and markets medical devices for fertility & women's health care | Health Technology |
Danmarks Eksport- og Investeringsfond
Danmarks Eksport- og Investeringsfond Investment ManagersFinance EIFO invests in small and medium-sized companies located in Denmark. The firm targets companies operating across a broad range of sectors and industries. It provides financing in the form of equity and debt with an investment size of DKK 5 - 200 million. It also takes a seat on the board of directors. | Finance |
University of Copenhagen
 University of Copenhagen Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Origio A/S
Origio A/S BiotechnologyHealth Technology Manufactures and markets assisted reproduction technologies and related human reproductive products | Health Technology |
ExpreS2ion Biotechnologies ApS
ExpreS2ion Biotechnologies ApS BiotechnologyHealth Technology Operates as a biotech company which engages in the field of protein production in Drosophila Schneider-2 cells | Health Technology |
Biosyntia ApS
Biosyntia ApS BiotechnologyHealth Technology Provides services in synthetic biology and metabolic engineering fields | Health Technology |
Expres2ion Biotech Holding AB
 Expres2ion Biotech Holding AB BiotechnologyHealth Technology Engages in the development of a portfolio of vaccines for diseases such as COVID-19, influenza, and breast cancer | Health Technology |
Hydract A/S
 Hydract A/S Industrial MachineryProducer Manufacturing Develops and manufactures water-hydraulic process valves and actuators for the food, beverage, dairy and pharmaceutical industries | Producer Manufacturing |
Agreena ApS
Agreena ApS Packaged SoftwareTechnology Services Operates as an agricultural technology company that offers soil carbon platform | Technology Services |
Monta ApS
Monta ApS Packaged SoftwareTechnology Services Provides EV ecosystem software solutions | Technology Services |
Choisissez Zonebourse 
